Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$490M |
| 2 |
Duke Energy
DUK
|
+$303M |
| 3 |
Gilead Sciences
GILD
|
+$164M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$159M |
| 5 |
Cisco
CSCO
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
KLA
KLAC
|
+$274M |
| 3 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$235M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$225M |
| 5 |
Microsoft
MSFT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.55% |
| 2 | Healthcare | 3.86% |
| 3 | Financials | 3.37% |
| 4 | Consumer Discretionary | 2.98% |
| 5 | Communication Services | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Elevance Health
ELV
$85.5B
| $2.79M | ﹤0.01% |
22,300
+8,800
| +65% | +$1.14M |
|
1702
Macerich
MAC
$6.92B
| $2.79M | ﹤0.01% |
34,531
-90,419
| -72% | -$7.64M |
|
|
RDS.B
1703
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $2.79M | ﹤0.01% |
52,822
+13,855
| +36% | +$742K |
|
1704
KeyCorp
KEY
$24.4B
| $2.78M | ﹤0.01% |
228,495
-263,122
| -54% | -$3.15M |
|
|
FL
1705
PUT
DELISTED
Foot Locker
FL
| $2.78M | ﹤0.01% |
41,000
-12,400
| -23% | -$773K |
|
1706
Waters Corp
WAT
$39.9B
| $2.78M | ﹤0.01% |
17,527
-4,148
| -19% | -$642K |
|
1707
PUT
Range Resources
RRC
$8.95B
| $2.77M | ﹤0.01% |
71,400
-16,700
| -19% | -$675K |
|
|
KSU
1708
PUT
DELISTED
Kansas City Southern
KSU
| $2.76M | ﹤0.01% |
29,600
+17,700
| +149% | +$1.68M |
|
1709
White Mountains Insurance
WTM
$5.13B
| $2.75M | ﹤0.01% |
3,319
-101
| -3% | -$83.2K |
|
1710
CALL
Vanguard FTSE Europe ETF
VGK
$31.1B
| $2.75M | ﹤0.01% |
56,400
-16,900
| -23% | -$813K |
|
|
ICPT
1711
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.75M | ﹤0.01% |
16,689
+5,165
| +45% | +$814K |
|
|
ITCI
1712
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.74M | ﹤0.01% |
+180,000
| New | +$7.28M |
|
1713
Tanger
SKT
$4.52B
| $2.73M | ﹤0.01% |
70,008
-43,287
| -38% | -$1.75M |
|
1714
Acadia Pharmaceuticals
ACAD
$5.03B
| $2.73M | ﹤0.01% |
85,716
-7,372
| -8% | -$250K |
|
1715
CALL
FMC
FMC
$1.33B
| $2.72M | ﹤0.01% |
64,914
-228,755
| -78% | -$9.42M |
|
1716
Woodward
WWD
$21.4B
| $2.72M | ﹤0.01% |
43,484
-23,683
| -35% | -$1.42M |
|
1717
Citizens Financial Group
CFG
$30.6B
| $2.71M | ﹤0.01% |
109,865
-558,493
| -84% | -$12.8M |
|
|
WNR
1718
PUT
DELISTED
Western Refining Inc
WNR
| $2.71M | ﹤0.01% |
102,392
-29,614
| -22% | -$700K |
|
1719
RPM International
RPM
$15B
| $2.7M | ﹤0.01% |
50,317
-521
| -1% | -$27.6K |
|
1720
Digital Realty Trust
DLR
$71.7B
| $2.7M | ﹤0.01% |
27,816
-122,445
| -81% | -$12.5M |
|
|
AVNS
1721
DELISTED
Avanos Medical
AVNS
| $2.7M | ﹤0.01% |
77,779
+43,860
| +129% | +$1.54M |
|
|
IPG
1722
DELISTED
Interpublic Group of Companies
IPG
| $2.69M | ﹤0.01% |
120,252
+32,170
| +37% | +$740K |
|
|
HIBB
1723
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.69M | ﹤0.01% |
67,328
+2,722
| +4% | +$102K |
|
|
RSX
1724
DELISTED
VanEck Russia ETF
RSX
| $2.69M | ﹤0.01% |
143,102
-68,787
| -32% | -$1.26M |
|
1725
CALL
Vale
VALE
$62.6B
| $2.68M | ﹤0.01% |
487,100
-1,487,200
| -75% | -$8.16M |
|
Similar funds
Barclays's Q3 2016 Portfolio in Review
As of Q3 2016, Barclays held 7,163 positions worth $90.1B, up 17% from $76.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $8.95B of net new capital in Q3 2016, opening 665 new positions and adding to 2,827 existing holdings. Its largest new stake was Dell: 9,434,097 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $593M trimmed.
- Barclays's largest Q3 2016 buy was Dell: 9,434,097 shares worth $127M.
- Barclays added most to Procter & Gamble in Q3 2016, an estimated $490M increase.
- Barclays's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $593M.
- Barclays fully exited EMC CORPORATION in Q3 2016, selling an estimated $225M.
- Barclays's ten largest holdings make up 36% of its $90.1B portfolio in Q3 2016.
- Barclays opened 665 new positions and closed 446 in Q3 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $90.1B.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.